These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8821899)

  • 1. Does recombinant human insulin-like growth factor I have a role in the treatment of type I (insulin dependent) diabetes during puberty?
    Dunger DB; Cheetham TD
    J Pediatr Endocrinol Metab; 1995; 8(4):237-42. PubMed ID: 8821899
    [No Abstract]   [Full Text] [Related]  

  • 2. Does IGF-I therapy in insulin-dependent diabetes mellitus limit complications?
    Møller N; Orskov H
    Lancet; 1997 Oct; 350(9086):1188-9. PubMed ID: 9652553
    [No Abstract]   [Full Text] [Related]  

  • 3. Growth hormone insulin-like growth factor I axis in insulin-dependent diabetes mellitus.
    Dunger DB; Cheetham TD
    Horm Res; 1996 Jul; 46(1):2-6. PubMed ID: 8854134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of repeated daily recombinant human insulin-like growth factor I administration in adolescents with type 1 diabetes.
    Cheetham TD; Holly JM; Clayton K; Cwyfan-Hughes S; Dunger DB
    Diabet Med; 1995 Oct; 12(10):885-92. PubMed ID: 8846679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-like growth factor-I for the treatment of type 1 diabetes.
    Acerini CL; Dunger DB
    Diabetes Obes Metab; 2000 Dec; 2(6):335-43. PubMed ID: 11225962
    [No Abstract]   [Full Text] [Related]  

  • 6. Cotherapy with recombinant human IGF-I and insulin improves glycemic control in type 1 diabetes.
    Lanzetta P; Malara C
    Diabetes Care; 2000 Mar; 23(3):436-7. PubMed ID: 10868894
    [No Abstract]   [Full Text] [Related]  

  • 7. Does recombinant insulin-like growth factor I have a role in the treatment of insulin-dependent diabetes mellitus during adolescence?
    Dunger DB; Cheetham TD; Holly JM; Matthews DR
    Acta Paediatr Suppl; 1993 Mar; 388():49-52; discussion 53. PubMed ID: 8329831
    [No Abstract]   [Full Text] [Related]  

  • 8. IGF-I and diabetes in adolescence.
    Dunger DB; Acerini CL
    Diabetes Metab; 1998 Apr; 24(2):101-7. PubMed ID: 9592633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin-like growth factor I: physiology, metabolic effects and clinical uses.
    Froesch ER; Hussain MA; Schmid C; Zapf J
    Diabetes Metab Rev; 1996 Oct; 12(3):195-215. PubMed ID: 8959385
    [No Abstract]   [Full Text] [Related]  

  • 10. Insulin and insulin-like growth factors in diabetes mellitus.
    Dunger DB
    Arch Dis Child; 1995 Jun; 72(6):469-71. PubMed ID: 7618926
    [No Abstract]   [Full Text] [Related]  

  • 11. Dual hormonal replacement therapy with insulin and recombinant human insulin-like growth factor (IGF)-I in insulin-dependent diabetes mellitus: effects on the growth hormone/IGF/IGF-binding protein system.
    Thrailkill K; Quattrin T; Baker L; Litton J; Dwigun K; Rearson M; Poppenheimer M; Kotlovker D; Giltinan D; Gesundheit N; Martha P
    J Clin Endocrinol Metab; 1997 Apr; 82(4):1181-7. PubMed ID: 9100593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Research on growth hormone (GH) and the insulin-like growth factors (IGFs).
    Le Roith D; Sonksen PH
    Growth Horm IGF Res; 1998 Feb; 8(1):1-2. PubMed ID: 10990438
    [No Abstract]   [Full Text] [Related]  

  • 13. Does recombinant human insulin-like growth factor-1 have a role in the treatment of diabetes?
    Dunger DB; Acerini CL
    Diabet Med; 1997 Sep; 14(9):723-31. PubMed ID: 9300221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant IGF-I therapy in insulin-dependent diabetes mellitus.
    Savage MO; Dunger DB
    Diabetes Metab; 1996 Jul; 22(4):257-60. PubMed ID: 8767172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The therapeutic potential of recombinant human insulin-like growth factor-I.
    Cotterill AM
    Clin Endocrinol (Oxf); 1992 Jul; 37(1):11-5. PubMed ID: 1424187
    [No Abstract]   [Full Text] [Related]  

  • 16. Growth hormone / insulin-like growth factor-1 axis during puberty.
    Christoforidis A; Maniadaki I; Stanhope R
    Pediatr Endocrinol Rev; 2005 Sep; 3(1):5-10. PubMed ID: 16369208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between the insulin resistance of puberty and the insulin-like growth factor-I/growth hormone axis.
    Moran A; Jacobs DR; Steinberger J; Cohen P; Hong CP; Prineas R; Sinaiko AR
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4817-20. PubMed ID: 12364479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The regulation of pubertal growth.
    Styne DM
    Horm Res; 2003; 60(Suppl 1):22-6. PubMed ID: 12955014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth and the child with diabetes mellitus.
    Clarke WL; Vance ML; Rogol AD
    Diabetes Care; 1993 Dec; 16 Suppl 3():101-6. PubMed ID: 8299467
    [No Abstract]   [Full Text] [Related]  

  • 20. Mecasermin (recombinant human insulin-like growth factor I).
    Rosenbloom AL
    Adv Ther; 2009 Jan; 26(1):40-54. PubMed ID: 19198769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.